Washington University Trial: Ketogenic Diet Cuts Liver Fat 67% in 4 Months
Washington University researchers found a ketogenic diet of 73 percent fat and 4 percent carbohydrate cut liver fat 67 percent in four months.
A clinical trial at Washington University School of Medicine found that a ketogenic diet reduced liver fat by 67 percent in four months, outperforming Mediterranean and low‑fat diets despite identical weight loss across all groups.
Researchers assigned 42 adults with obesity, prediabetes and non‑alcoholic fatty liver disease to one of three diets providing meals prepared by the study team. Each participant lost roughly 10 percent of starting body weight over four to five months.
The ketogenic group, consuming 73 percent of calories from fat and 4 percent from carbohydrate, saw mean intrahepatic triglyceride content drop 67 percent. The Mediterranean diet group (50 percent carbohydrate) and the low‑fat, plant‑based group (70 percent carbohydrate) each recorded a 45 percent reduction, Cumhuriyet reported.
“Weight loss alone does not explain the difference,” said Samuel Klein, the study’s senior author and director of the Center for Human Nutrition at Washington University. “Carbohydrate restriction appears to trigger a distinct hormonal milieu that mobilizes hepatic fat stores directly.”
Glycemic improvement tracked with the hepatic changes. Half of the ketogenic diet participants no longer met criteria for prediabetes at the end of the intervention, compared with 29 percent in the Mediterranean group and 7 percent in the low‑fat group.
Fasting insulin fell sharply in the ketogenic arm while glucagon rose to the highest levels observed across the three arms, a hormonal profile consistent with enhanced hepatic fat oxidation, lead author Max Petersen said.
Despite deriving three‑quarters of daily calories from fat, ketogenic dieters showed no increase in serum triglycerides or total cholesterol. Serial 24‑hour blood sampling confirmed the metabolic shift without the atherogenic lipoprotein response often anticipated with high saturated‑fat intake. The findings were published in Cell Metabolism.
Investigators cautioned that longer, larger studies are needed to determine whether the hepatic and glycemic advantages persist beyond the active weight‑loss phase and translate into reduced cardiovascular events. Patients considering a therapeutic ketogenic regimen should discuss individualized monitoring with a hepatologist or metabolic specialist.
Washington University School of Medicine, founded in 1891 after St. Louis Medical College affiliated with the university, shares its campus with Barnes‑Jewish Hospital and St. Louis Children’s Hospital in the Central West End of St. Louis. The school operates Washington University Physicians, a practice covering more than 75 specialties that staffs its two teaching hospitals and additional sites across the region.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.